Drug: posaconazole

Manufacturer: misc

Route of Administration: Oral

Site of Care: Outpatient

Approved Indication:

• prophylaxis of invasive Aspergillus and Candida infections in patients who are at high risk of developing these infections due to being severely immunocompromised, such as hematopoietic stem cell transplant recipients with graft-versus-host disease or those with hematologic malignancies with prolonged neutropenia from chemotherapy
• treatment of oropharyngeal candidiasis (OPC), including OPC refractory to itraconazole and/or fluconazole

Disease: aspergillosis, candidiasis

Therapeutic Area: Infectious disease

Enrollment Form Link: N/A

Phone Number: N/A

Fax Number: N/A

Product Website: N/A